Current price is more than the intrinsic value
Stock has been generating better return on equity than bank FD
Stock offers good dividend returns
Good time to consider, as stock is not in overbought zone
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
GlaxoSmithKline Pharmaceuticals is a pharmaceutical company engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in pharmaceuticals, vaccines and consumer healthcare.
Customise key metrics, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
2 weeks ago•Business Today
2 weeks ago•Bloomberg Quint
2 weeks ago•India Infoline
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Voting results, Scrutinizer report and Proceedings of Annual General Meeting held on 26-Jul-2022 | Download
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Voting results, Scrutinizer report and Proceedings of Annual General Meeting held on 26-Jul-2022 | Download
Special • Div/Share: ₹ 60
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is more than the intrinsic value